Pfizer sees about $15 billion in 2021 sales from Covid-19 vaccine
Global Economy
02 February, 2021, 06:05 pm
Last modified: 02 February, 2021, 06:05 pm
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion
A man walks past a sign outside Pfizer Headquarters in the Manhattan borough of New York City, New York, US, July 22, 2020. Photo:Reuters
Pfizer Inc on Tuesday forecast sales of about $15 billion from the coronavirus vaccine that it is making along with German partner BioNTech.
The company said it expects total 2021 revenue of between $59.4 billion and $61.4 billion.
Comments
While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.